Italian Government Defies Court Ruling, Lists CBD as Narcotic

Jul.15.2024
Italian Government Defies Court Ruling, Lists CBD as Narcotic
Italy defies EU law, listing CBD as narcotic. Italy's move sparks backlash from hemp industry, threatens 10,000 jobs.

According to a report from Hemptoday on July 12, the Italian government has ignored a ruling from a regional administrative court and violated EU law by placing CBD on the country's list of narcotic drugs.


The Italian Ministry of Health stated that this regulation complies with Italian Presidential Decree 309/1990, which forms the cornerstone of Italy's drug legislation. However, this contradicts a ruling from a regional court last year, which was based on legally binding judgments within the European Union.


This is the latest move by the Italian government against CBD. In October 2020, the Ministry of Health classified CBD as a narcotic drug for the first time and banned it from the market, but soon after revoked the order.


In another attempt in early 2022, the national-regional conference updated the language in the 2018 regulation, officially categorizing marijuana as a medicinal plant.


In that scenario, four major cannabis associations filed a lawsuit and the Lazio Regional Administrative Court overturned the regulation a year later, ruling that it violated European law. The European Commission announced in 2020 that CBD is not a narcotic drug and can be legally traded between member states. This decision was based on a landmark ruling by the European Court of Justice the same year.


The Italian Farmers' Association, Cia-Agricoltori Italiani, criticized the government in a statement for not consulting producers before listing CBD as a dangerous drug, stating that this move "has insulted farmers who have invested money and work in the industrial hemp supply chain in recent years".


The farmer's organization stated that


This is not only a controversial measure from legal, health, and scientific perspectives, but also an intervention that could potentially make the already heavily strained supply chain even more complicated.


According to CIA-Agricoltori Italiani, these prejudices are further reflected in a current amendment in the Italian parliament, which aims to ban CBD and all other products derived from hemp flowers.


The group's chairman, Cristiano Fini, stated that


We are facing potential ideological interference that could paralyze a high-value-added supply chain that attracts young people. This supply chain has huge production potential in cosmetics, herbs, green construction, floriculture, and textiles, with an annual turnover of 500 million euros and providing over 10,000 jobs.


Currently circulating in parliament is a proposed amendment that would completely ban cannabis flowers, affecting various aspects of production and trade. The leading cannabis industry organization, Federcanapa, has expressed that the provisions would effectively shut down the sub-industry of cannabis extracts, affecting the use of CBD and other non-psychoactive cannabinoids in herbal remedies, cosmetics, and dietary supplements.


Some lawmakers and other experts have stated that the amendment would result in the closure of 3,000 businesses and the unemployment of 15,000 workers.


Finney stated that Cia-Agricoltori Italiani has invited government representatives to discuss with CBD operators.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Nicotine Pouch Startup Sesh Raises $40 Million, Backed by 8VC and Celebrity Investors
Nicotine Pouch Startup Sesh Raises $40 Million, Backed by 8VC and Celebrity Investors
U.S. nicotine pouch startup Sesh has secured $40 million in funding, led by 8VC, with contributions from Post Malone, Diplo, and Andrew Schulz. The company, co-developed by Zyn inventor Thomas Ericsson, has submitted a marketing application to the FDA and is permitted to operate in the U.S. market. Sesh, now headquartered in Austin, has about 30 employees and its products are available in over 5,000 stores across the U.S. and Canada.
Sep.05
PMI Japan to Launch Limited Edition IQOS ILUMA i "Galaxy Blue", Introduces New TEREA Clear Regular Flavo
PMI Japan to Launch Limited Edition IQOS ILUMA i "Galaxy Blue", Introduces New TEREA Clear Regular Flavo
PMI Japan unveils limited edition IQOS ILUMA i in Galaxy Blue, inspired by the universe, set to launch on October 29.
Oct.14 by 2FIRSTS.ai
Reuters: FDA relaxes requirements for nicotine pouch pilot program, cancels special research on some products
Reuters: FDA relaxes requirements for nicotine pouch pilot program, cancels special research on some products
US FDA meeting minutes: Under Trump, a new pilot eases nicotine pouch rules—cuts product-specific research (uses generic data), shortens reviews, boosts communication. It’s the FDA’s first clear softer stance on smoking alternatives. The pilot may benefit Philip Morris (Zyn), Altria (On!), BAT (Velo) but sparks debate: FDA says pouches are low-risk (no youth surge), while ex-officials/academics cite missing research (hurts health checks, risks hidden youth use). Firms note costly research remain
Sep.19 by 2FIRSTS.ai
The Russian government approved a bill requiring e-cigarette and cigarette sales to be licensed from March 2026
The Russian government approved a bill requiring e-cigarette and cigarette sales to be licensed from March 2026
The Russian government has approved a bill submitted to the State Duma that proposes implementing a licensing system for the sale of cigarettes and e-cigarettes, covering wholesale, retail, and delivery, starting March 1, 2026. Sales to minors could result in license revocation, and large-scale illegal trading would face criminal penalties.
Sep.28 by 2FIRSTS.ai
U.S. Conservative Commentator Charlie Kirk on Vaping Policy: Crackdown on Independent Vape Firms Could Force Adult Users Back to Cigarettes and the Black Market
U.S. Conservative Commentator Charlie Kirk on Vaping Policy: Crackdown on Independent Vape Firms Could Force Adult Users Back to Cigarettes and the Black Market
Charlie Kirk published an opinion piece in April criticizing current e-cigarette regulations, arguing that excessive oversight and litigation are not genuinely aimed at protecting youth but rather driven by political and corporate interests. He noted that this approach would force millions of adult users to lose access to low-risk alternatives, potentially pushing them back to cigarettes or toward black market products, ultimately harming public health.
Sep.11 by 2FIRSTS.ai
Opinion | Samrat Chowdhery: Tobacco Price Elasticity—A Convenient Myth?
Opinion | Samrat Chowdhery: Tobacco Price Elasticity—A Convenient Myth?
This opinion piece, submitted by Samrat Chowdhery to 2Firsts, challenges the logic of tobacco price elasticity. It argues that high taxes often harm vulnerable populations and fuel illicit markets rather than reducing smoking.
Oct.21